Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cidara Thera (NQ: CDTX ) 14.38 +0.48 (+3.45%) Streaming Delayed Price Updated: 1:52 PM EST, Nov 14, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Cidara Thera < Previous 1 2 3 4 5 Next > Cidara Therapeutics' Unique Cloudbreak Platform And Its Promise In Influenza And Oncology Today 9:07 EST CDTX sold its Rezayo business to concentrate on its MDC-producing Cloudbreak platform which has already produced several promising drug candidates, like CD388, a very promising clinical-stage... Via Talk Markets This Cytokinetics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday November 08, 2024 Via Benzinga CDTX Stock Earnings: Cidara Therapeutics Beats EPS, Misses Revenue for Q2 2024 August 13, 2024 CDTX stock results show that Cidara Therapeutics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. Via InvestorPlace CDTX INVESTOR NOTICE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Cidara Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation - CDTX May 16, 2024 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Regulatory Compliance Exposures Legal Regulatory CDTX INVESTOR NOTICE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Cidara Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation - CDTX May 16, 2024 WHY: NEW YORK, NY - (NewMediaWire) - May 16, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Cidara... Via TheNewswire.com Topics Regulatory Compliance Exposures Legal Regulatory Why Cidara Therapeutics (CDTX) Stock Is Falling April 22, 2024 Cidara Therapeutics shares are trading lower by 24.4% Monday afternoon. The company announced a 1-for-20 reverse stock split. Via Benzinga CDTX Stock Earnings: Cidara Therapeutics Misses EPS, Misses Revenue for Q1 2024 May 15, 2024 CDTX stock results show that Cidara Therapeutics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. Via InvestorPlace CDTX INVESTOR NEWS: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Cidara Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – CDTX May 14, 2024 From The Rosen Law Firm PA Via GlobeNewswire CDTX LOSS ALERT: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Cidara Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation - CDTX May 13, 2024 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Regulatory Compliance Exposures Legal Regulatory CDTX LOSS ALERT: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Cidara Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation - CDTX May 13, 2024 WHY: NEW YORK, NY - (NewMediaWire) - May 13, 2024 - Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Cidara... Via TheNewswire.com Topics Regulatory Compliance Exposures Legal Regulatory CIDARA Therapeutics ALERT: Bragar Eagel & Squire, P.C. is Investigating Cidara Therapeutics, Inc. on Behalf of Cidara Therapeutics Stockholders and Encourages Investors to Contact the Firm April 25, 2024 From Bragar Eagel & Squire Via GlobeNewswire Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session April 25, 2024 Via Benzinga CDTX LOSS ALERT: ROSEN, A LEADING LAW FIRM, Encourages Cidara Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – CDTX April 25, 2024 From The Rosen Law Firm, P.A. Via Business Wire Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday April 25, 2024 Pre-market stock movers are a great way to start Thursday as we check out all of the hottest news moving shares this morning! Via InvestorPlace Why Teradyne Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket April 25, 2024 Via Benzinga Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session April 23, 2024 Via Benzinga Why Hibbett Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket April 23, 2024 Via Benzinga CDTX Stock Earnings: Cidara Therapeutics Beats EPS, Beats Revenue for Q4 2023 April 22, 2024 CDTX stock results show that Cidara Therapeutics beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023. Via InvestorPlace 12 Health Care Stocks Moving In Wednesday's After-Market Session February 14, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session January 30, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session December 25, 2023 Via Benzinga Crude Oil Rises Over 1%; Cidara Therapeutics Shares Spike Higher September 06, 2023 U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling more than 1% on Wednesday. The Dow traded down 0.57% to 34,443.02 while the NASDAQ fell 1.19% to 13,853.60. The S&P... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities 12 Health Care Stocks Moving In Wednesday's Intraday Session September 06, 2023 Via Benzinga Why Core & Main Are Trading Lower By 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session September 06, 2023 Gainers Palisade Bio, Inc. (NASDAQ: PALI) shares jumped 114% to $1.47. Palisade Bio transformed GI-focused pipeline through exclusive worldwide licensing agreement with Giiant Pharma, Inc. for multiple... Via Benzinga Why Is Infectious Diseases Focused Cidara Therapeutics Stock Trading Higher Today? September 06, 2023 Cidara Therapeutics Inc (NASDAQ: CDTX) shares are trading higher after the company announced that Janssen Pharmaceuticals Inc, a unit of Johnson & Johnson (NYSE: JNJ), decided to pr Via Benzinga Want to Get Rich? 3 Game-Changing Penny Stocks to Buy Right Now August 28, 2023 While the very concept of penny stocks to buy is treacherous, these analyst-backed ideas could be enticing for the smart speculator. Via InvestorPlace Cidara Therapeutics And 3 Other Stocks Under $3 Insiders Are Buying August 09, 2023 The Dow Jones closed lower by over 150 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... Via Benzinga Janssen To Discontinue Internal Development Of Cidara Therapeutics-Partnered Influenza Candidate July 21, 2023 Cidara Therapeutics Inc (NASDAQ: CDTX) provided an update on the status of its ongoing CD388 program for the prevention of influenza A and B under an exclusive worldwide license and collaboration... Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session June 22, 2023 Via Benzinga Why Heron Therapeutics Shares Are Trading Lower By 34%? Here Are Other Stocks Moving In Friday's Mid-Day Session May 12, 2023 Gainers GSI Technology, Inc. (NASDAQ: GSIT) shares surged 108% to $3.4207. GSI Technology is expected to announce financial results for its fiscal fourth quarter after the market close on May 16,... Via Benzinga < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
